Mikhail Melnikov (M V Melnikov)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Immune Response

Multiple Sclerosis

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

A V Lopatina, Anastasia Sviridova, O O Belousova, U Sh Kuzmina, Mikhail Melnikov
[The role of dopamine receptors in the modulation of mononuclear phagocytes in multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (7. Vyp. 2) (2024)
Mikhail Melnikov, A V Lopatina, Anastasia Sviridova, M V Pashenkov, Alexey Boyko
[The influence of fluoxetine on neuroimmune interaction in multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (7. Vyp. 2) (2023)
Mikhail Melnikov, Anastasia Sviridova, Vladimir Rogovskii, Alexey Boyko, M V Pashenkov
[The role of macrophages in the development of neuroinflammation in multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (5) (2022)
A V Lopatina, A D Kukushkina, Mikhail Melnikov, Vladimir Rogovskii
[Prospects for the use of polyphenols in multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (7. Vyp. 2) (2022)
Mikhail Melnikov, Anastasia Sviridova, T V Solodova, A V Lopatina, M V Pashenkov, Alexey Boyko
[Blockade of D1-like dopaminergic receptors suppresses Th17-cell function in multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (7. Vyp. 2) (2021)
Mikhail Melnikov, M V Pashenkov, Alexey Boyko
[The prospect of dopaminergic therapy in multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (2) (2021)
Mikhail Melnikov, Svetlana Sharanova, Anastasiya Sviridova, Vladimir Rogovskii, Nina Murugina, Anna Nikolaeva, Yulia Dagil, Vladimir Murugin, Tatiana Ospelnikova, Alexey Boyko, Mikhail Pashenkov
The influence of glatiramer acetate on Th17-immune response in multiple sclerosis. PloS one 15 (10) (2020)
L V Krivenko, Anastasia Sviridova, Mikhail Melnikov, Vladimir Rogovskii, Alexey Boyko, M V Pashenkov
[The influence of fluoxetine on interleukin-6 and interleukin-1β production by dendritic cells in multiple sclerosis in vitro]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (7. Vyp. 2) (2020)
Alexey Boyko, Mikhail Melnikov, M S Kozin, O G Kulakova
[The role of mitochondria in pathological mechanisms of innate immunity in multiple]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (7. Vyp. 2) (2020)
Mikhail Melnikov, Vladimir Rogovskii, Alexey Boykо, Mikhail Pashenkov
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 15 (1) (2019)